Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

Presumed Asymptomatic Carrier Transmission of COVID-19

(2020) Yan Bai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

(2020) Hongzhou Lu et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States

(2020) Christina L. Dean et al.   TRANSFUSION

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

(2020) Wei Zhang et al.   Emerging Microbes & Infections

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

(2020) Chenguang Shen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

(2020) Kai Duan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Points to consider in the preparation and transfusion of COVID‐19 convalescent plasma

(2020) Jay Epstein et al.   VOX SANGUINIS

SARS and MERS: recent insights into emerging coronaviruses

(2016) Emmie de Wit et al.   NATURE REVIEWS MICROBIOLOGY

Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment

(2016) Shawn D. Keil et al.   TRANSFUSION

Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States

(2016) Roger Y. Dodd et al.   TRANSFUSION

Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro

(2016) Andrew P. Cap et al.   TRANSFUSION

Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment

(2015) Shawn D. Keil et al.   TRANSFUSION

Risk factors for retrovirus and hepatitis virus infections in accepted blood donors

(2014) Brian Custer et al.   TRANSFUSION

Inactivation ofPlasmodiumspp. in plasma and platelet concentrates using riboflavin and ultraviolet light

(2013) Shawn D. Keil et al.   TRANSFUSION

Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment – A comparative study

(2013) Bela Balint et al.   TRANSFUSION AND APHERESIS SCIENCE

Component pathogen inactivation: a critical review

(2012) C. V. Prowse   VOX SANGUINIS

Recently Discovered Human Coronaviruses

(2009) Brigitte A. Wevers et al.   CLINICS IN LABORATORY MEDICINE

Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins

(2009) Valerie S. Hornsey et al.   TRANSFUSION

Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma

(2009) James Smith et al.   TRANSFUSION